Page last updated: 2024-11-02

4-phenylbutyric acid and Carcinoma, Non-Small Cell Lung

4-phenylbutyric acid has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, M1
Jiang, Y1
Wu, H1
Shi, W1
Lu, G1
Cong, D1
Liu, K1
Song, S1
Ren, J1
Jin, X1
Wu, N1
Dai, J1
Li, Q1
Xiao, X1

Other Studies

2 other studies available for 4-phenylbutyric acid and Carcinoma, Non-Small Cell Lung

ArticleYear
Gambogic Acid Shows Anti-Proliferative Effects on Non-Small Cell Lung Cancer (NSCLC) Cells by Activating Reactive Oxygen Species (ROS)-Induced Endoplasmic Reticulum (ER) Stress-Mediated Apoptosis.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, May-29, Volume: 25

    Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; China; Endoplasmic Reticulum C

2019
TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment.
    Cancer medicine, 2017, Volume: 6, Issue:2

    Topics: A549 Cells; Butyric Acid; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Caspase 3; Caspase 7; Ce

2017